Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Andrew Green's Biography



Andrew Green, Senior Drug Discovery Specialist, Discoverx

Andrew is an experienced pharmacologist having worked in Pharma for over 20 years supporting preclinical programs; principally on GPCRs and small molecule discovery. Notable areas of research were receptor deorphanisation and study of GPCR heterodimerisation: he has published extensively in these fields and in his current role still takes a keen interest in new areas of research such ligand bias. For the last 5 years his role within DiscoverX Europe has been to provide scientific, drug discovery and technical expertise to the organization whilst interfacing with academia and commercial partners. Recent emphasis has been on developing partnerships focused on Biologics and large molecules across all stages of their research and development. He now also provides expertise on Bioseek’s phenotypic assay platform

Andrew Green Image

Enabling Cancer Immunotherapy, From Target to Phenotype

Monday, 6 March 2017 at 14:15

Add to Calendar ▼2017-03-06 14:15:002017-03-06 15:15:00Europe/LondonEnabling Cancer Immunotherapy, From Target to PhenotypeSELECTBIOenquiries@selectbiosciences.com

This presentation will highligh innovative microtiter plate based assays to interrogate immune checkpoint receptors and introduce KILR™


Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com